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Abstract
 
Pseudomonas aeruginosa
 
 is an important opportunistic human pathogen. Certain strains can trans-
migrate across epithelial cells, and their invasive phenotype is correlated with capacity to cause
invasive human disease and fatal septicemia in mice. Four multidrug efflux systems have been
described in 
 
P. aeruginosa
 
, however, their contribution to virulence is unclear. To clarify the
role of efflux systems in invasiveness, 
 
P. aeruginosa
 
 PAO1 wild-type (WT) and its efflux mutants
were evaluated in a Madin-Darby canine kidney (MDCK) epithelial cell monolayer system and
in a murine model of endogenous septicemia. All efflux mutants except a 
 
 
 
mexCD-oprJ
 
 dele-
tion demonstrated significantly reduced invasiveness compared with WT. In particular, a
 
 
 
mexAB-oprM
 
 deletion strain was compromised in its capacity to invade or transmigrate across
MDCK cells, and could not kill mice, in contrast to WT which was highly invasive (
 
P
 
 
 
 
 
0.0006) and caused fatal infection (
 
P
 
 
 
 
 
 0.0001). The other mutants, including 
 
 
 
mexB
 
 and
 
 
 
mexXY
 
 mutants, were intermediate between WT and the 
 
 
 
mexAB-oprM
 
 mutant in invasive-
ness and murine virulence. Invasiveness was restored to the 
 
 
 
mexAB-oprM
 
 mutant by comple-
mentation with
 
 mexAB
 
-
 
oprM 
 
or by addition of culture supernatant from MDCK cells infected
with WT. We conclude that the 
 
P. aeruginosa
 
 MexAB-OprM efflux system exports virulence
determinants that contribute to bacterial virulence.
Key words:
 
Pseudomonas aeruginosa
 
 • bacterial invasion • multidrug efﬂux system • outer 
membrane protein • endogenous bacteremia
 
Introduction
 
Pseudomonas aeruginosa
 
 is a versatile Gram-negative bacte-
rium that is an important opportunistic human pathogen.
Although this organism does not cause bloodstream infec-
tions in patients with chronic respiratory infections despite
long-term colonization, it can be invasive in other patients
and cause bacteremia associated with high mortality rates,
particularly in those with neutropenia. We have reported
that most clinical blood isolates cause lethal endogenous
bacteremia in leukopenic mice, whereas human respiratory
isolates do not cause bacteremia (1, 2). We have also re-
ported that clinical blood isolates of 
 
P. aeruginosa
 
 penetrate
human intestinal Caco-2 and Madin-Darby canine kidney
(MDCK)
 
*
 
 epithelial cell monolayers to a greater extent
than do respiratory isolates (3, 4). In the MDCK epithelial
cell monolayer system, PAO1 and most blood isolates are
invasive but lack 
 
exoU
 
, which encodes a 70-kD cytotoxic
protein ExoU (5, 6), and showed high penetration ability
without severe epithelial damage. In contrast, PA103 and
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8% of clinical isolates are cytotoxic, possess 
 
exoU
 
, and
pass through the monolayer after epithelial cell death (4).
 
P. aeruginosa
 
 is intrinsically resistant to conventional peni-
cillins and cephems due to its low outer membrane (OM)
permeability coupled to the production of an inducible
chromosomal 
 
 
 
-lactamase, which hydrolyzes these 
 
 
 
-lac-
tams (7) and can become mutationally resistant to even
newly-developed antipseudomonal agents (8). In addition
to the recent emergence of metallo-
 
 
 
-lactamase producing
 
P. aeruginosa
 
 (9), multidrug resistant (MDR) efflux systems
are becoming recognized as important antimicrobial resis-
tance mechanisms for this organism. To date, four resis-
tance-nodulation-division (RND) MDR efflux systems
have been described in 
 
P. aeruginosa
 
: MexAB-OprM (10–
13); MexCD-OprJ (14); MexEF-OprN (15); and MexXY-
OprM (16, 17, for a review, see references 18–21). The
genes encoding these systems are arranged as operons, with
the first gene encoding a linker protein that is associated
with the cytoplasmic membrane (MexA, MexC, MexE,
and MexX). The second gene encodes an efflux pump that
exports substrates across the inner membrane (MexB,
MexD, MexF, and MexY). In three cases, a third gene en-
codes an OM protein, which facilitates passage of the sub-
strate across the OM (OprM, OprJ, and OprN). OprM is
also involved in the MexXY-OprM system (16, 22). The
three components form a channel that traverses the inner
membrane, periplasm, and OM and allows the substrate to
be effluxed directly from the cytoplasm or cytoplasmic
membrane to the extracellular environment (18). Among
these four efflux systems, only MexAB-OprM is expressed
constitutively in wild-type (WT) 
 
P. aeruginosa
 
. It was the
first 
 
P. aeruginosa
 
 MDR efflux system to be described, and
contributes to intrinsic resistance to a number of antimicro-
bials, such as fluoroquinolones, 
 
 
 
-lactams, tetracycline,
macrolides, chloramphenicol, novobiocin, trimethoprim,
and sulphonamides (18). In contrast, other systems have dif-
ferent substrate spectra and are not expressed during normal
laboratory growth (18). In addition to medically relevant
antibiotics, MexAB-OprM also exports a variety of dyes,
detergents, inhibitors of fatty acid biosynthesis, and organic
solvents (18). Hence, this and other RND efflux systems are
generally thought to expel harmful substances from bacteria.
Recently, certain studies have suggested a relationship
between efflux and virulence in 
 
P. aeruginosa
 
. For instance,
it has been reported that MexAB-OprM exports ho-
moserine lactones which are involved in quorum sensing
(cell-to-cell signaling; references 23–25) and consequent
regulation of the expression of a variety of virulence deter-
minants. Thus, 
 
nalB
 
 mutants which hyperexpress the
MexAB-OprM efflux system produce reduced levels of sev-
eral extracellular virulence factors (25). Other studies have
demonstrated that, compared with WT, 
 
nfxC
 
 type mutants,
overexpressing the MexEF-OprN efflux system, produce
lower levels of pyocyanin, elastase, and rhamnolipids, which
are controlled by the 
 
las
 
 and 
 
rhl
 
 quorum-sensing systems
(26, 27). It has also been suggested that MexAB-OprM
contributes to the antibiotic resistance of 
 
P. aeruginosa
 
 bio-
films (28), while other studies have reported the obverse in-
 
dicating that the four characterized efflux systems described
above did not play a significant role in the resistance of 
 
P.
aeruginosa
 
 biofilm to antibiotics (29). However, the role of
efflux systems in specific clinical pathogenesis of 
 
P. aerugi-
nosa
 
, including invasiveness, has not been determined.
To gain a better understanding the role of efflux in bac-
terial pathogenesis, the invasiveness of 
 
P. aeruginosa
 
 PAO1
and its efflux mutants was evaluated using in vitro MDCK
epithelial cell monolayer penetration (4, 30, 31) and gen-
tamicin survival (31, 32) assays, and by electron micros-
copy. Virulence was also investigated in a murine model of
endogenous 
 
P. aeruginosa
 
 bacteremia, closely mimicking
the pathophysiology of septicemia in humans (2, 33, 34).
 
Materials and Methods
 
Bacterial Strains and Construction of Mutants.
 
Bacterial strains and
plasmids used in this study are summarized in the Table I. 
 
P.
aeruginosa
 
 PAO1 strain K767 (35) was used as the WT, which is
invasive and penetrates MDCK cell monolayers by 3 h after in-
fection (4). Strain K767 lacks 
 
exoU
 
 and did not show any cyto-
toxicity to MDCK cells within 6 h after infection. To construct
 
P. aeruginosa
 
 deletion mutants, the deletions were first made in
 
sacB
 
-containing vectors and were subsequently introduced into
the chromosome of K767 by gene replacement (36). The
 
mexAB-oprM
 
 deletion strain K1119 (37) and the 
 
mexCD-oprJ
 
 de-
letion strain K1521 (29) were constructed using the 
 
mexAB-oprM
 
deletion construct pRSP21 and the 
 
mexCD-oprJ
 
 deletion con-
struct pRSP05, respectively, using the strategy reported previ-
ously (38). In these instances, however, the selections of
transconjugants carrying a copy of pRSP21 or pRSP05 were on
Luria-Bertani (LB) agar containing 1.5 mg of kanamycin per ml.
The 
 
mexXY
 
 deletion strain K1525 was constructed as described
previously (29). To construct the 
 
mexB
 
 deletion strain K1523, a
4.6–kb KpnI-HindIII fragment from pRSP19 (39), containing
 
mexA
 
 and part of 
 
mexB
 
, was first cloned into pEX18Tc to gener-
ate pRSP77. Plasmid pRSP77 was digested with BamHI and
MluI at two unique sites within 
 
mexB
 
, 1.8-kb apart, and the 9.1-
kb fragment containing the vector was isolated. This fragment
was treated with Klenow (New England Biolabs) to facilitate
back filling of the 3
 
 
 
 recessed ends and ligated to yield pRSP81.
The internal deletion in 
 
mexB
 
 created in this manner was con-
firmed to be in-frame by sequencing pRSP81 with primer
bacmexbf1 (5
 
 
 
-ATG TCG AAG TTT TTC ATT GAT AGG-
3
 
 
 
). Plasmid pRSP81 was mobilized into 
 
P. aeruginosa
 
 strain K767
and a chromosomal 
 
mexB
 
 deletion selected using the protocol de-
scribed previously for the 
 
mexXY
 
 deletion (29).
The chromosomal deletion of 
 
mexB
 
 was confirmed by PCR
using primers rspoligo3 (5
 
 
 
-CAG CAG CTC TAC CAG ATC
GAC-3
 
 
 
) and rspoligo4 (5
 
 
 
-GTG TCC TTG GTC AGC TGC
AAC-3
 
 
 
). The 
 
nfxB
 
 strain K1536 was obtained after plating
strain K767 on LB plates containing 0.4 
 
 
 
g ciprofloxacin
(Sigma-Aldrich) per ml. Those overexpressing MexCD-OprJ
were confirmed by immunoblotting of cell envelopes with anti-
bodies specific to OprJ as described previously (38). The 
 
nalB
 
strain OCR1 has been described previously (35). Plasmids
pRK415 (40) and its derivative pRSP17 (39), which carries
 
mexAB-oprM
 
 were maintained in strain K1119 (
 
 
 
mexAB-oprM
 
)
by inclusion of tetracycline (10 
 
 
 
g/ml) in the growth media. To
constructe a 
 
oprM
 
 knockout mutant derived from K767 (WT),
PCR primers for amplification of the 1.5-kb fragment were syn- 
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thesized based on nucleotide sequences of the 
 
Pseudomonas
 
 ge-
nome sequencing project database. After amplifying a 1.5-kb re-
gion including 
 
oprM
 
 gene (11) on strain K767 (WT) genomic
DNA as a template using #oprM4 (5
 
 
 
-TCATAAGCTTAT-
GAAAACGGTCCTTCCTTTCC-3
 
 
 
) and #oprM3 (5
 
 
 
-TTG-
AGAATTCTCAAGCCTGGGGATCTTCCTT-3
 
 
 
), a primer
pair containing a newly added cutting site (underlined) for re-
striction nucleases, the region was ligated into the HindIII-
EcoRI site in a multicloning site of pMT5059 (41) to yield
pMT5059M. The SalI fragment encompassing 
 
 
 
Sm gene from
pS1918 (42) was ligated into the SalI site in the 
 
oprM
 
 gene on
pMT5059M to yield pMT5059MSM. Then, the Mob cassette
from pMT5071 (43) was cloned into the NotI site, on pMT5059
(41) to yield pMK1. The resulting plasmid was mobilized from
the
 
 E. coli 
 
strain S17–1 to K767 (WT) to introduce the strepto-
mycin-resistant determinant into the 
 
oprM 
 
gene on the recipient
chromosomes to yield KG4521. Disruption of the 
 
oprM
 
 gene of
KG4521 was confirmed by PCR and Western immunoblot anal-
ysis using the anti-OprM antibody (44) (unpublished data). Plas-
mid pKMM128 (45) carrying
 
 oprM 
 
was maintained in KG4521
(
 
 oprM) in the presence of 10  g/ml of carbenicillin. All mu-
tants derived from K767 were motile, resistant to 10% pooled
fresh normal human serum, noncytotoxic, and grew in LB broth
and MEM as well as their parent strain K767.
MDCK Cell Monolayer Penetration Assay. The assay was per-
formed as reported previously (4, 30, 31). In brief, strain 1
MDCK cells in MEM with 10% FBS were seeded at 1.5   105
cells per well in Transwell filter units (Costar) containing 0.33-
cm2 porous filter membranes (3.0- m pores). Monolayers were
incubated at 37 C in 5% CO2 for 4 d until the transmonolayer
electrical resistance (TER) reached the proper range (900–1,200
 cm2), as measured with a Millicell-ESR apparatus (Millipore).
Monolayers were infected with bacteria by adding 5  l (3.5  
106 CFU) freshly grown bacteria cultured in LB broth overnight
at 37 C with shaking at 150 rpm. In some experiments, TER was
monitored at several time intervals after infection to assess damage
to monolayers. The assay was performed in triplicate, and results
are expressed as an average   SD. Each assay was repeated at least
three times to confirm the reproducibility.
Bacterial Association and Invasion Assay. Gentamicin survival as-
says were performed to quantify the bacteria which invaded
MDCK cells (31, 32). After a 3-h infection, monolayers were
washed six times with PBS and then incubated a further 2 h in
fresh medium containing 200  g/ml of gentamicin to kill extra-
cellular bacteria only. Monolayers were washed three times with
PBS and then lysed with a 1% Triton X-100 (Sigma-Aldrich) for
15 min. Appropriate dilutions were spread onto agar plates, incu-
bated at 37 C overnight, and CFUs counted to quantify bacteria
surviving intracellularly. Associated bacteria (including both ad-
herent and invading bacteria) were measured by the addition of a
1% Triton X-100 to the monolayers 3 h after infection followed
by six washes without gentamicin treatment. As a control, filter
units with medium only and without MDCK cells were inocu-
lated with bacteria to determine baseline adherence to plastic.
The baseline values were subtracted from those obtained by incu-
bation with epithelial cells as described above.
Electron Microscopy. For transmission electron microscopy (TEM),
monolayers infected with bacteria were washed seven times with
PBS at 37 C and fixed in 2.5% glutaraldehyde in 0.1 M sodium
cacodylate containing 2 mM CaCl2 (cacodylate buffer) for 60 min.
After washing with cacodylate buffer, samples were postfixed in
cold 1% OsO4 in the same buffer for 30 min, and then stained
with cold 2% uranyl acetate for 30 min. Samples were dehydrated
in a series of ethanol and embedded in EPON 812 resin, and were
sectioned and stained with uranyl acetate and lead citrate before
examination in a JEOL JEM-1210 transmission electron micro-
scope. For scanning electron microscopy (SEM), the monolayers
were fixed as described above, dehydrated in a critical point appa-
ratus, and were examined with a JEOL JSM-35C/LaB6 III–A
scanning electron microscope, after a gold sputter coating.
Evaluation of Virulence of the Efflux Mutants in a Murine Model of
Endogenous Bacteremia. The animal studies were approved by the
Animal Care and Use Committee of Nagasaki University, and
were conducted in accordance to the Guidelines for Animal Ex-
Table I. Bacterial Strains and Plasmids Used in this Study
Strain or plasmid Relevant genotype or phenotype Source or reference
P. aeruginosa strains
K767 WT PAO1 35
K1119 K767  mexAB-oprM; MexAB-OprM deletion strain 37
K1521 K767  mexCD-oprJ; MexCD-OprJ deletion strain 29
K1523 K767  mexB; MexB deletion strain this study
K1525 K767  mexXY; MexXY deletion strain 29
OCR1 K767 nalB; MexAB-OprM overproducing strain 35
K1536 K767 nfxB; MexCD-OprJ overproducing strain this study
KG4521 K767 oprM:Sm; oprM knockout mutant this study
Plasmids
pRK415 Broad-host-range cloning vector, tetracycline-resistant 40
pRSP17 pRK415:mexAB-oprM; mexAB-oprM expression plasmid 39
pKMM128 oprM expression plasmid, carbenicillin-resistant 45112 Invasiveness of Pseudomonas aeruginosa and Efflux Systems
perimentation, Nagasaki University. Specific-pathogen-free male
BALB/c mice (Japan S.L.C. Co., Ltd.) weighing 20–24 g were
used in these experiments. Fecal specimens were cultured before
the study to ensure the absence of P. aeruginosa. Endogenous bac-
teremia was induced as described previously (2, 33, 34). In brief, a
suspension of 107 CFU/ml P. aeruginosa in sterile 0.45% saline
was given in the drinking water between days 1 and 4. The nor-
mal intestinal flora of the mice was disturbed by administration of
sodium ampicillin (Meiji Seika Kaisha, Ltd.) by daily intraperito-
neal injection during the same period, to assist in the colonization
by P. aeruginosa. Mice were then given 200 mg/kg cyclophospha-
mide (Shionogi & Co.) by intraperitoneal injection on days 5, 7,
and 9. These doses of cyclophosphamide induce leukopenia
( 1,000/mm3) in mice from days 8 to 14 without lethality in the
absence of oral bacterial inoculation (33, 34).
Effect of Monolayer Supernates on Penetration of P. aeruginosa
Strains. The supernates of monolayers infected with strains
K767 (WT) or K1119 ( mexAB-oprM) were collected 3 h or
overnight after infection of MDCK cells, and diluted appropri-
ately. The medium of the MDCK cell monolayers on day 4 was
replaced with these supernates and strains K767 or K1119 were
added 1 h later as described above. As controls, the supernates
from MDCK cell-free MEM or LB broth inoculated with the
strains were also tested.
Statistics. Analysis of variance (ANOVA) was used for the
comparisons among three or more groups. Student’s t test was
used to compare means between the two groups. Chi-square test
was used to compare survival rates. A level of 5% was accepted as
statistically significant.
Results
Penetration of Strain K767 (WT) and Its Efflux Mutants
through MDCK Cell Monolayers. Both the parent WT strain
K767 and strain K1521 ( mexCD-oprJ) penetrated MDCK
monolayers by 3 h, whereas K1119 ( mexAB-oprM) was
not detected in the basolateral medium until 6 h after infec-
tion (Fig. 1 A). At all time points, the penetration of both
K767 (WT) and K1521 ( mexCD-oprJ) was significantly
greater than that for K1119 ( mexAB-oprM) (P   0.0006,
ANOVA). Compared with the WT, relative capacities of
the mutants to penetrate monolayers at 3 and 6 h after in-
fection are summarized in Fig. 1 B. Strains K1523 ( mexB)
and K1525 ( mexXY) were also compromised for invasion,
but to lesser extents than the mutant with total deletion of
mexAB-oprM (K1119). The invasive capacities of strains
OCR1 (nalB) and K1536 (nfxB), hyperexpressing efflux
systems, were also intermediate between strains K767
(WT) and K1119 ( mexAB-oprM).
Fig. 2 shows the time course of changes in TER of the
MDCK cell monolayers infected with strain K767 (WT)
and its efflux mutants. TER of monolayers infected with
strains K767 (WT) or K1521 ( mexCD-oprJ) decreased in
a time-dependent manner. The drops in TER for these
strains were slower than that for cytotoxic strains, which
induced a steep drop (4). When monolayers were infected
with strain K1119 ( mexAB-oprM), TER decreased more
slowly over time than for strains K767 (WT) and K1521
( mexCD-oprJ). The values of TER for strains K1523
( mexB) and K1525 ( mexXY) were always intermediate
between those of strains K767 (WT) and K1119
( mexAB-oprM).
Association and Invasion of Strains K767 (WT) and K1119
( mexAB-oprM). Strain K1119 ( mexAB-oprM) adhered
to MDCK cells, as well as K767 (WT) (5.25   1.79   105
vs. 4.78   1.21   105 CFU, not significant, Fig. 3 A).
However, the gentamicin survival assay revealed that the
efflux mutant K1119 ( mexAB-oprM) showed a signifi-
cantly decreased level of invasion (86.7   9.6 vs. 1.18  
0.15   104 CFU, P   0.0002, Fig. 3 B). Fig. 3 C shows
the time courses of invasion for the strains K767 (WT) and
K1119 ( mexAB-oprM) by the gentamicin survival assay.
Significantly greater numbers of K767 (WT) than K1119
( mexAB-oprM) invaded the epithelial cells (P   0.0065, at
each time point). Strain K767 (WT), which penetrated
monolayers by 3 h (Fig. 1 A), entered the cells within 30
min, and the number of intracellular bacteria per mono-
layer increased in a time-dependent manner. The small
number of K1119 ( mexAB-oprM) which had transversed
the monolayers by 6 h (Fig. 1 A), was reflected in by the
low level of invasion by 60 min. The number of intracellu-
lar K1119 ( mexAB-oprM) bacteria also increased in a
time-dependent manner, but the value at 360 min was
comparable to K767 (WT) only 60 min after infection (200  
45 vs. 130   17 CFU, P   0.0653).
Electron Microscopy. When observed by scanning elec-
tron microscopy, most of the bacteria, including strain
K767 (WT) and its efflux mutants, adhered near the edge
(cell-to-cell junctions) of MDCK cells (Fig. 4 A), whereas
Figure 1. Penetration of P. aeruginosa strain K767 (WT) and its efflux
mutants. Bacteria were inoculated at 3.5   106 CFU per well to the api-
cal surfaces of MDCK cell monolayers. (A) The assay was performed in
triplicate, and results are expressed as mean   SD. (B) The values are ex-
pressed as percentages of values obtained with strain K767 at 3 and 6 h.113 Hirakata et al.
K767 (WT) showed an additional adherence pattern, ad-
herence around the center of the epithelial cells and
seemed to be in the process of invading (Fig. 4 B). The mi-
crovilli of MDCK cells, to which P. aeruginosa isolates ad-
hered, were grossly unaltered. Transmission electron mi-
croscopy showed that K767 (WT) contacted with the
epithelial cell surface (Fig. 4 C) and a bacterium was inter-
nalized (Fig. 4 D) 15 min after infection. At later time
points bacteria invaded into the cells and reached the layer
of the polycarbonate filter within 3 h after infection, as re-
ported elsewhere (46, 47) but without appearance of cell
injury. In contrast, K1119 ( mexAB-oprM) did not pene-
trate at all by 30 min, and only a small number of bacteria
invaded cells by 3 h after infection (data not shown).
Evaluation of the Virulence of the Efflux Mutants in a Murine
Model. The animal model used in this study reflects the
differences in the important pathophysiological steps in au-
thentic human infections, including bacterial colonization
and invasion. All strains of P. aeruginosa tested survived
equally well in the drinking water; all were recovered at
equal titer at the end of the oral bacterial challenge. Fur-
thermore, on day 8, equivalent numbers of P. aeruginosa
were recovered from the stools of animals challenged with
each different bacterial strain. Strains K767 (WT) and
K1521 ( mexCD-oprJ) induced lethal endogenous septice-
mia in mice, whereas strain K1119 ( mexAB-oprM) failed
to kill any mice (P   0.0001, Fig. 5 A). The mortality rates
of mice given K1523 ( mexB, 20% mortality rate, P  
Figure 2. Changes of TER after infection with P. aerug-
inosa strain K767 (WT of PAO1) and its efflux mutants.
TER was measured in triplicate, and results are expressed
as an average   SD of area multiplied by resistance.
Figure 3. Bacterial association with (A) and invasion into (B and C)
MDCK epithelial cells of P. aeruginosa strain K767 (WT of PAO1) and its
efflux mutant K1119 ( mexAB-oprM). Bacterial association was evaluated
by lysis of the epithelial cells with Triton X-100, 3 h after infection. Bacte-
rial invasion was assessed at indicated times similarly but after the treatment
with 200  g/ml of gentamicin for 2 h to kill extracellular bacteria. The assay
was performed in triplicate, and results are expressed as mean   SD.
Figure 4. Scanning (A and B) and transmission (C and D) electron mi-
crographs of MDCK epithelial cell monolayers infected with P. aeruginosa
strain K767 (WT of PAO1) and its efflux mutants K1119 ( mexAB-oprM).
Bacteria adhere near the edge of the epithelial cells without loss of mi-
crovilli (A; K1119, 3 h after infection). Bacteria adhere around the center
of the epithelial cells and some bacteria appear to be invading into the
MDCK cells, without loss of microvilli (B; K767, 1 h after infection).
Bacteria are contacting the epithelial cell surface (C; K767) and a bacte-
rium is internalized into a MDCK cell (D; K767) 15 min after infection.
Original magnifications, 4,800  (A and B) and 10,000  (C and D). Bar,
1  m.114 Invasiveness of Pseudomonas aeruginosa and Efflux Systems
0.0001 compared with K767), K1525 ( mexXY, 55%, P  
0.00066), OCR1 (nalB, 80%, P    0.035), and K1536
(nfxB, 70%, P   0.0079) were intermediate between those
for strains K767 (100%) and K1119 (0%) (Fig. 5 B).
Influence of Complementation of K1119 ( mexAB-oprM)
with mexAB-oprM on Its Invasiveness. To confirm the role
of  mexAB-oprM in the expression of invasiveness, the
 mexAB-oprM deletion strain K1119 was complemented
with mexAB-oprM by introducing plasmid pRSP17 carry-
ing the genes and examined with strains K767 (WT),
K1119 ( mexAB-oprM), and K1119/pRK415 (plasmid
control). K1119/pRSP17 (mexAB-oprM complemented
strain) showed the invasiveness equivalent to WT in both
in vitro (Fig. 6 A) and the animal model (Fig. 6 B), while
plasmid control strain K1119/pRK415 had the same phe-
notype, which was compromised in its capacity to pene-
trate MDCK monolayer (Fig. 6 A, P   0.0001) and to
kill leukopenic mice (Fig. 6 B, P    0.0001) as K1119
( mexAB-oprM).
Influence of a Single Mutation in oprM on the Invasiveness of
P. aeruginosa. A oprM knockout mutant KG4521 was ex-
amined with K767 (WT) and KG4521/pKMM128 (oprM
complemented strain) to clarify the role of OprM in the
loss of virulence in P. aeruginosa. Strain KG4521 (oprM
knockout) was significantly less virulent in the MDCK epi-
thelial monolayer system (Fig. 6 A, P   0.0466) and in the
animal model (Fig. 6 B, P   0.02703). However, the loss
of virulence was modest compared with the complete
mexAB-oprM deletion mutant K1119. Complementation of
KG4521 with oprM restored the virulence entirely (Fig. 6).
Effect of Monolayer Supernates on Penetration of P. aeruginosa
Strains. Experiments were performed to determine if sol-
uble factors enhanced the penetration of P. aeruginosa across
MDCK cells. Neither supernates of K767 (WT) or K1119
( mexAB-oprM) cultured overnight in cell-free LB broth,
nor K1119 ( mexAB-oprM) cultured overnight in MEM in
the presence of MDCK cells, when readded to MDCK
cells, influenced the penetration of K767 (WT). On the
other hand, the supernate from MDCK cells incubated
overnight together with K767 (WT), caused a slight but
significant enhancement of the penetration of strain K767
(WT) itself into MDCK monolayers (P    0.0475,
ANOVA). Supernates from MDCK cell monolayers in-
fected overnight with K767 (WT) dramatically and signifi-
cantly enhanced the penetration of K1119 ( mexAB-oprM)
into MDCK cells (P    0.0001, ANOVA). The K1119
( mexAB-oprM) supernate also significantly enhanced the
penetration of K1119 ( mexAB-oprM) (P   0.05), but the
Figure 5. Survival kinetics of leukopenic mice given P. aeruginosa strain
K767 (WT) and its efflux mutants K1119 ( mexAB-oprM) and K1521
( mexCD-oprJ) (A) and mortality rates of mice given P. aeruginosa WT
and its efflux mutants (B). Mice were given 200 mg of ampicillin (A) and
200 mg of cyclophosphamide (CY) per kg on the indicated days. Bacteria
were given orally in drinking water in sterile 0.45% saline at the concen-
tration of 107 CFU/ml between days 1 and 4. The numbers of mice per
group are indicated in the figure. (B) Data are expressed as the mortality
rate for each group given a different P. aeruginosa strain.
Figure 6. Penetration of P. aeruginosa strain K767 (WT), K1119
( mexAB-oprM), mexAB-oprM complemented strain, and oprM knockout
mutant (A) and mortality rates of leukemic mice given the P. aeruginosa
strains (B). Strains K1119/pRSP17 and K1119/pRK415 are K1119
( mexAB-oprM), complemented with mexAB-oprM and its plasmid con-
trol, respectively. KG4521 and KG4521/pKMM128 are oprM knockout
mutant from K767 and oprM complemented mutant of KG4521, respec-
tively. The assay was performed in triplicate, and results are expressed as
mean   SD (A). Data are expressed as the mortality rate for each group
(at least 10 mice per group) given a different P. aeruginosa strain (B).115 Hirakata et al.
effect was nearly 10-fold less than that observed with the
K767 (WT) supernate (245   128 vs. 2320   385, P  
0.0081) (Fig. 7 A). The supernates of K767 (WT) incu-
bated in MEM in the absence of MDCK cells showed a
very low level of enhancement of invasion of the K1119
( mexAB-oprM) cells (unpublished data). The supernates of
strain K767 (WT) incubated with MDCK cells overnight,
enhanced the penetration of strain K1119 ( mexAB-oprM)
through monolayers in a concentration-dependent manner
(Fig. 7 B). In contrast, the supernates obtained 3 h after in-
fection demonstrated a relatively weak enhancement effect
compared with those from overnight cultures.
Discussion
This study using MDCK epithelial cell monolayer sys-
tem demonstrates an association between bacterial efflux
mechanisms and invasion of eukaryotic cells. The
 mexAB-oprM deletion strain K1119 was the least invasive
among the efflux mutants tested, while K1521, the
mexCD-oprJ deletion strain, was as invasive as WT. The
loss of only mexB (K1523) or mexXY (K1525) decreased in-
vasion but in a less dramatic fashion than for the deletion of
the entire mexAB-oprM operon (K1119). Data from gen-
tamicin survival assays, electron microscopy studies, and the
animal studies supported these findings. The current in
vitro and in vivo animal models represent intestinal epithe-
lium and gut-derived endogenous bacteremia, respectively,
but not respiratory epithelium nor pneumonia models.
Mex and OM proteins may influence the bacterial suscepti-
bility to antibody independent complement killing or op-
sonic killing by neutrophils; however, all mutants in this
study were serum-resistant as the WT, suggesting that the
mutations did not affect their susceptibility to antibody-
independent complement killing. This study did not include
phagocytes in the in vitro system and our animal model
was leukopenic. Therefore, we do not believe that the
changes we observed in the mutants influenced their inter-
actions with phagocytic cells.
Our data suggest that deletion of all three genes in the
MexAB-OprM efflux system is necessary to yield the
maximum loss of invasiveness. The complementation of
 mexAB-oprM deletion strain K1119 with mexAB-oprM re-
stored the invasiveness to the level of WT, and conse-
quently confirmed that the genes, mexAB-oprM, actually
played an important role in the loss of invasiveness. The
MexXY-OprM and MexAB-OprM systems share OprM
as a channel-tunnel (16, 17), and only the deletion of genes
in these two efflux systems decreased the level of invasive-
ness modestly. However, the mexB deletion strain K1523
displayed a more similar phenotype to the complete
mexAB-oprM mutant K1119 than the mexXY mutant
K1525. The difference in virulence between the  mexB
mutant and the  mexXY mutant may depend on the ex-
pression of each efflux system; MexAB-OprM is expressed
constitutively. We expected that OprM is a critical deter-
minant of invasiveness in P. aeruginosa and that the invasive
determinant(s) are exported through OprM only; however,
the loss of invasiveness in the oprM knockout mutant,
KG4521 was modest, suggesting the possibility that OM
proteins other than OprM also could work with MexAB.
The efflux system-overproducing strains such as nalB and
nfxB, also demonstrated somewhat reduced invasiveness,
akin to the efflux deletion strains (Fig. 1 B). These para-
doxical findings may be explained by recent reports, which
showed that nalB type mutants, hyperexpressing the
MexAB-OprM (23–25) and nfxC type mutants, overex-
pressing the MexEF-OprN (26, 27), produce lower level of
virulence factors because of their influence on cell-to-cell
signaling regulated by quorum-sensing systems. Therefore,
it appears that normal efflux levels are necessary for P.
aeruginosa to express maximal invasiveness.
Data from gentamicin survival assays (Fig. 3 A) and elec-
tron microscopy studies (Fig. 4 A) also confirmed that the
differences between WT and the  mexAB-oprM mutant in
Figure 7. Influence of bacterial culture supernates on penetration of P.
aeruginosa strain K767 (WT of PAO1) and its efflux mutant K1119
( mexAB-oprM) (A) and the effect of concentration of supernates (B).
MDCK cell monolayers were infected with K767 or K1119 overnight
and the supernates were collected. Medium of MDCK cell monolayers
were replaced 1 h before infection with the supernates obtained in the
different condition as described. Fresh MEM was used as a control. The
assay was performed in triplicate, and results are expressed as mean   SD.
Legend: sup in LB, bacterial culture supernate from LB broth; sup in
MEM/MDCK, bacterial culture supernate from MDCK cell monolayer
infected with bacteria;. sup 3 h, bacterial culture supernate from MDCK
cell monolayer infected for 3 h; sup O/N, bacterial culture supernate
from MDCK cell monolayer infected overnight.116 Invasiveness of Pseudomonas aeruginosa and Efflux Systems
bacterial penetration through MDCK epithelial cell mono-
layers, were correlated with differences in their invasive-
ness; the strains adhered to the epithelial cells equally well.
Electron microscopy studies showed a very similar invasion
pattern to that reported in the study using tracheal epithe-
lial cells (48). Interestingly, in contrast to the observation of
microvilli loss when MDCK cells are infected with Salmo-
nella isolates for at least 2 h (31), microvilli appeared to re-
main intact when such cells were infected with P. aerugi-
nosa strains for at least 3 h. The difference between the two
bacterial species is consistent with the observation that P.
aeruginosa frequently colonizes the intestine of normal hu-
man subjects (49) without producing any symptoms, and
shares characteristics with normal enteric microbial flora.
Conversely, Salmonella species are not part of the normal
flora and have the capacity to cause invasive disease in nor-
mal hosts. The molecular mechanisms accounting for dif-
ferences in the pathology of disease in the gastrointestinal
tract remains unexplained in spite of the reported use of the
cystic fibrosis transmembrane conductance regulator by
both Salmonella typhi and P. aeruginosa to enter epithelial
cells (50–52). Recently, it has been reported that S. typhi
LPS is altered by contact with epithelial cells, exposing the
bacterial ligand for cystic fibrosis transmembrane conduc-
tance regulator on the LPS (53). Similar findings in P.
aeruginosa–epithelial cell interaction could further clarify the
molecular mechanisms of invasion for this bacterial species.
Our previous study demonstrated that noncytotoxic iso-
lates of P. aeruginosa, including PAO1, expressed minimal
epithelial cell damage; PAO1 did not induce LDH release
from MDCK cells or the formation of plaques as detected
by staining with trypan blue at 6 h after infection; cytotoxic
isolates showed clear evidence of cell damage within 3 h
(4). In this study, changes in TER of monolayers infected
with the efflux mutants, in particular the mexAB-oprM de-
letion strain, were substantially less than for the WT (Fig.
2). These findings may mean that bacterial invasion may
disrupt the tight junctions between epithelial cells even
though they do not induce demonstrable cytotoxicity.
The supernates from MDCK cells infected overnight
with WT restored the capacity of the  mexAB-oprM strain
K1119 to penetrate monolayers in a concentration-depen-
dent manner (Fig. 7). When the WT strain was added from
the basolateral side, neither the basolateral nor apical super-
nates showed any enhancing effect (data not shown). The
enhancement of invasion by the K1119 ( mexAB-oprM)
supernate was modest, and much less than by the WT su-
pernate, suggesting that other efflux systems may export
virulence determinants, albeit to a lesser degree than for
MexAB-OprM. These findings strongly indicate that WT
exports invasion determinant(s) into the extracellular envi-
ronment, using predominantly MexAB-OprM (with lesser
contributions by MexXY-OprM or other undetermined
systems). It remains to be determined if the putative deter-
minant(s) of invasiveness act directly as invasive factor(s) or
as regulatory factor(s). Although it is still possible that
mammalian products could be involved in the findings,
studies are currently underway to purify and determine the
molecular nature of the determinant(s) in the bacterial su-
pernate which confer invasiveness.
The recovery of invasiveness of the mexAB-oprM dele-
tion strain, mediated by the supernate of WT, required
cell-to-cell contact between the bacterium and MDCK
cells (Fig. 7). These data suggest that the type III protein se-
cretion system (for a review, see reference 54) may be in-
volved in the expression of invasiveness in P. aeruginosa.
Type III secretion systems require close contact between
bacterium and eukaryotic cell in order to deliver virulent
bacterial proteins directly into the cytoplasm of the cell.
ExoU and some other exoenzymes are recognized type III
effectors in P. aeruginosa (55). In other bacterial species such
as Salmonella, the bacteria modulate actin organization to
induce their own uptake by nonphagocytic cells (56, 57).
Efflux protein homologues can secrete proteins since type I
secretion systems are RND homologues (58). However,
the relation of efflux systems to the type III protein secre-
tion system has not been demonstrated to date, and proteins
secreted by the type III systems are likely too large for ex-
port via MDR efflux systems. Therefore, it is possible that
contact of bacteria with the epithelial cells may be a trigger
to stimulate the efflux of invasiveness determinant(s).
Our findings in this study strongly suggest that invasion
determinant(s) are predominantly exported by P. aeruginosa
via MexAB-OprM. Hence, MDR efflux systems in P.
aeruginosa might be critical for the efflux of virulence factors,
in addition to their established role of exporting harmful
substances such as antibiotics or detergents. It seems practi-
cal for bacteria to utilize efflux systems to export virulence
determinants and physiological products, as a physiological
process. In fact, recent reports suggest that E. coli expels bac-
terial cellular metabolites such as indole and bile acids using
the efflux systems AcrEF (59) and AcrAB (60), respectively.
Our findings are consistent with a novel physiological role
for such “multidrug” efflux systems, namely in enhancing
bacterial invasiveness in P. aeruginosa infections. Further-
more, efflux inhibitors, which are under development to
depress MDR by efflux systems (61), may also serve to re-
duce bacterial invasiveness in P. aeruginosa infections.
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